Theory and strategy for Pneumococcal vaccines in the elderly. - Wikidata - wikimedia - TriplyDB

Theory and strategy for Pneumococcal vaccines in the elderly.

Theory and strategy for Pneumococcal vaccines in the elderly.

http://www.wikidata.org/entity/Q37309215

about

Invasive pneumococcal disease caused by mucoid serotype 3 Streptococcus pneumoniae: a case report and literature review.What do we know about the cost-effectiveness of pneumococcal conjugate vaccination in older adults?Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.

P2860

Q36241461-880A9FAD-6367-4A6D-A0D9-742160966CB9 Q37375898-75765B9A-4298-40D5-8BA9-D83E797A7A4E Q39278063-42B7836A-D230-4475-B837-BD1FB07F92E2

P2860

Theory and strategy for Pneumococcal vaccines in the elderly.

http://www.wikidata.org/entity/Q37309215

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 September 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Theory and strategy for Pneumococcal vaccines in the elderly.

@en

Theory and strategy for Pneumococcal vaccines in the elderly.

@nl

type

label

Theory and strategy for Pneumococcal vaccines in the elderly.

@en

Theory and strategy for Pneumococcal vaccines in the elderly.

@nl

prefLabel

Theory and strategy for Pneumococcal vaccines in the elderly.

@en

Theory and strategy for Pneumococcal vaccines in the elderly.

@nl

P1433

Q37309215-BE1F88A9-B50B-429D-BAFD-C19E32813674

P1476

Q37309215-FC638E71-E273-439C-A769-CE67FA5BB1AC

P2093

Q37309215-16034BD2-7AFD-4D8C-AE96-83BD1FA37A12

Q37309215-46005E4C-4062-4232-896E-251CDFA2B642

Q37309215-57C31318-0DD6-4FBF-8CC5-045D1A491C71

Q37309215-6D3905CD-3029-4BD1-BAB9-8C834BBEEC5E

Q37309215-78CF3191-A5B2-40DD-9586-B218FAE62E75

Q37309215-79C8BC39-1D32-486F-A5DF-0910CB38A3FA

Q37309215-A3CDDFB9-7861-4D1D-A6EF-DB260691B0F6

Q37309215-B7D312D0-C4FF-49FA-A1FE-C9FA35101508

Q37309215-F0F3C436-65F9-4AD7-A170-535896F67D6B

Q37309215-F8F72FB4-6052-40BE-8962-73D3321308D9

P2860

Q37309215-008F15DB-7D6B-4198-ADF0-4C8C55242EBC

Q37309215-00F15523-624A-4B7F-8681-FE14DADD374D

Q37309215-034DE03F-CA6A-4177-BC7D-C027802CD7E3

Q37309215-08766733-DF64-4791-ABAE-8D4E042A598D

Q37309215-0E19269C-F24C-4D3D-A812-7ED4C82D9E5E

Q37309215-0F576BE6-6C9E-41BD-A7E7-595459D348F5

Q37309215-15FE15DC-86B1-458C-8588-89714F2ADD8F

Q37309215-16E91831-AE74-4D48-B37A-8DCDDADA92F0

Q37309215-189F44A0-5C66-482F-B280-3FE9313D5EDC

Q37309215-18B7C881-5F05-45AD-840C-6A9FB26ED06D

P304

Q37309215-BA8E317C-52B7-44C2-BCCD-F804953072C9

P31

Q37309215-5B59E869-6EEA-4BA5-A198-0E185A79D122

P356

Q37309215-CA66E22B-4A00-4ED8-ABFB-A224D87C60A5

P433

Q37309215-EF5A2782-507F-4494-BC5A-07377BEDA435

P478

Q37309215-F115985C-7354-4553-8CA6-212087D389C9

P50

Q37309215-B5F59E13-4CAC-41A3-9EE0-DEB018750CE1

Q37309215-D6052947-339E-475B-B9AD-7B07078F3A77

P577

Q37309215-B672DAF2-01D8-4C4C-9AAB-D2EBFBB0D6F4

P698

Q37309215-1A00CF92-22D1-407B-83C0-5C14CDB36B66

P932

Q37309215-E00BD703-B5BD-43CB-8EB8-8B339C80E123

P356

21645515.2015.1075678

P1433

Human Vaccines & Immunotherapeutics

P1476

Theory and strategy for Pneumococcal vaccines in the elderly.

@en

P2093

Hiroshi Fujiwara

http://www.w3.org/2001/XMLSchema#string

Ho Namkoong

http://www.w3.org/2001/XMLSchema#string

Kazuma Yagi

http://www.w3.org/2001/XMLSchema#string

Naoki Hasegawa

http://www.w3.org/2001/XMLSchema#string

Sadatomo Tasaka

http://www.w3.org/2001/XMLSchema#string

Shoji Suzuki

http://www.w3.org/2001/XMLSchema#string

Takahiro Asami

http://www.w3.org/2001/XMLSchema#string

Testuro Kamo

http://www.w3.org/2001/XMLSchema#string

Tomoko Betsuyaku

http://www.w3.org/2001/XMLSchema#string

Yohei Funatsu

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

Vaccines for preventing pneumococcal infection in adults

A systems biology approach to the effect of aging, immunosenescence and vaccine response

Pneumococcal vaccination of older adults: conjugate or polysaccharide?

The role of vaccination in preventing pneumococcal disease in adults

Immunogenicity and reactogenicity of pneumococcal polysaccharide and conjugate vaccines in alaska native adults 55-70 years of age.

Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study.

Towards a comprehensive public health response to population ageing.

High incidence of septic shock caused by Streptococcus pneumoniae serotype 3--a retrospective epidemiological study

P304

336-343

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2015.1075678

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Takanori Asakura

P577

2015-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26406267

http://www.w3.org/2001/XMLSchema#string

P932

5049722

http://www.w3.org/2001/XMLSchema#string